##{"id":100676,"date":"2022-04-04T10:35:45","date_gmt":"2022-04-04T00:35:45","guid":{"rendered":"https:\/\/www.fnarena.com\/?p=100676"},"modified":"2022-04-04T10:35:47","modified_gmt":"2022-04-04T00:35:47","slug":"australian-broker-call-extra-edition-apr-04-2022","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2022\/04\/04\/australian-broker-call-extra-edition-apr-04-2022\/","title":{"rendered":"Australian Broker Call *Extra* Edition &#8211; Apr 04, 2022"},"content":{"rendered":"<p><strong>An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed&nbsp;equities.<\/strong><\/p>\n<p>In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena&nbsp;has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed&nbsp;stocks, also enlarging the number of stocks that make up the FNArena&nbsp;universe.<\/p>\n<p>One key difference is the *Extra* Edition will not be updated daily, but merely &quot;regularly&quot; depending on availability&nbsp;of&nbsp;suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.<\/p>\n<p>Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication&nbsp;may not be up to date, or yet awaiting another update by FNArena&#039;s&nbsp;team of journalists.<\/p>\n<p>Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.<\/p>\n<p>The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.<\/p>\n<p>The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.<\/p>\n<p><strong>COMPANIES DISCUSSED IN THIS ISSUE<\/strong><\/p>\n<p>Click on a symbol for fast access.<br \/>The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)<\/p>\n<p><a href=\"#COI\" style=\"font-weight:bold\">COI<\/a>&nbsp;&nbsp; <a href=\"#PPS\" style=\"font-weight:bold\">PPS<\/a>&nbsp;&nbsp; <a href=\"#QUB\" style=\"font-weight:bold\">QUB<\/a>&nbsp;&nbsp; <a href=\"#SGM\" style=\"font-weight:bold\">SGM<\/a>&nbsp;&nbsp; <a href=\"#SIG\" style=\"font-weight:bold\">SIG<\/a>&nbsp;&nbsp; <a href=\"#STN\" style=\"font-weight:bold\">STN<\/a>&nbsp;&nbsp; <a href=\"#TAH\" style=\"font-weight:bold\">TAH<\/a>&nbsp;&nbsp; <a href=\"#TWE\" style=\"font-weight:bold\">TWE<\/a>&nbsp;&nbsp; <a href=\"#UWL\" style=\"font-weight:bold\">UWL&nbsp;(2)<\/a>&nbsp;&nbsp;<\/p>\n<h2><a name=\"COI\">COI<\/a>&nbsp;&nbsp;&nbsp; COMET RIDGE LIMITED<\/h2>\n<p><strong>NatGas &#8211; Overnight Price: $0.18 <\/strong><\/p>\n<p>Bell Potter rates ((COI)) as Buy (1) &#8211;<\/p>\n<p>Comet Ridge has received the necessary&nbsp;government approvals for its acquisition of a 30% stake in the Mahalo gas project. Joint venture documentation with Santos ((STO)) is underway with completion expected in the June quarter according to Bell Potter.<\/p>\n<p>With production tests of the Mahalo North wells expected, the broker notes&nbsp;Comet Ridge will solidify its position with appraisal of the project&#039;s gas production.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $0.25 from $0.19.<\/p>\n<p>This report was published on April 1, 2022.<\/p>\n<p>Target price is <strong>$0.25<\/strong> Current Price is <strong>$0.18 <\/strong> Difference: <strong>$0.07<\/strong><br \/>If <strong>COI<\/strong> meets the Bell Potter target it will return approximately <strong> 39%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.60<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 30.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.70<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 25.71<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"PPS\">PPS<\/a>&nbsp;&nbsp;&nbsp; PRAEMIUM LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $0.70 <\/strong><\/p>\n<p>Shaw and Partners rates ((PPS)) as Buy (1) &#8211;<\/p>\n<p>Praemium has announced changes to its management team, including a new CEO and COO, as the last step in its future growth&nbsp;strategy, but&nbsp;Shaw and Partners notes the appointment of new management suggests Netwealth Group&#039;s ((NWL)) bid is no more.<\/p>\n<p>The apparent cessation of the bid drives the broker&nbsp;to remove its 30% premium, resulting in a target price decline. Elsewhere, high costs have impacted on first half results and full year guidance, and the broker anticipates market reaction is likely negative.<\/p>\n<p>The Buy rating is retained and the target price decreases to $1.30 from $1.70.<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$1.30<\/strong> Current Price is <strong>$0.70 <\/strong> Difference: <strong>$0.6<\/strong><br \/>If <strong>PPS<\/strong> meets the Shaw and Partners target it will return approximately <strong> 86%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.20<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 350.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>0.90<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>77.78<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"QUB\">QUB<\/a>&nbsp;&nbsp;&nbsp; QUBE HOLDINGS LIMITED<\/h2>\n<p><strong>Transportation &amp; Logistics &#8211; Overnight Price: $3.11 <\/strong><\/p>\n<p>Jarden rates ((QUB)) as Buy (1) &#8211;<\/p>\n<p>Jarden notes Australian container volume movements remain robust, with movements in February only -6.4% below&nbsp;all-time peak levels in October 2020.<\/p>\n<p>Despite this&nbsp;statistic, the broker stays conservative on its&nbsp;Qube Holdings&#039; forecasts as&nbsp;inventory rebuilds at retailers begin to slow. Additionally,&nbsp;the impact of contributions from prior-year acquisitions in the container division&nbsp;is diminishing.<\/p>\n<p>The Buy rating and $3.65 target price are retained.<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$3.65<\/strong> Current Price is <strong>$3.11 <\/strong> Difference: <strong>$0.54<\/strong><br \/>If <strong>QUB<\/strong> meets the Jarden target it will return approximately <strong> 17%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$3.32<\/strong>, suggesting upside of <strong>6.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> EPS of <strong>8.60<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>36.16<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>9.6<\/strong>, implying annual growth of <strong>98.8%<\/strong>.<br \/>Current consensus DPS estimate is <strong>6.2<\/strong>, implying a prospective dividend yield of <strong>2.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>32.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> EPS of <strong>10.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>30.79<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>11.2<\/strong>, implying annual growth of <strong>16.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>7.0<\/strong>, implying a prospective dividend yield of <strong>2.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>27.8<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SGM\">SGM<\/a>&nbsp;&nbsp;&nbsp; SIMS LIMITED<\/h2>\n<p><strong>Steel &amp; Scrap &#8211; Overnight Price: $21.56 <\/strong><\/p>\n<p>Jarden rates ((SGM)) as Buy (1) &#8211;<\/p>\n<p>Despite Sims highlighting (at its investor day) the benefits from higher ferrous and non-ferrous commodity prices in March, and noting intake volumes remain solid,&nbsp;Jarden&nbsp;doesn&#039;t raise&nbsp;its above-consensus forecasts.&nbsp;The Buy rating and $23 target price are retained.<\/p>\n<p>The broker points out China will lift&nbsp;scrap metal imported to 343m tonnes&nbsp;by 2030 from 248m tonnes in 2020,&nbsp;and has been&nbsp;increasing the amount of scrap imported from countries such as Japan.<\/p>\n<p>As a result of this move by China, the&nbsp;analyst sees an opportunity for Sims&nbsp;to increase exports to Asian countries that used to import Japanese scrap.<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$23.00<\/strong> Current Price is <strong>$21.56 <\/strong> Difference: <strong>$1.44<\/strong><br \/>If <strong>SGM<\/strong> meets the Jarden target it will return approximately <strong> 7%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$20.68<\/strong>, suggesting downside of <strong>-4.1%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>75.70<\/strong> cents and EPS of <strong>255.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.51%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>8.43<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>248.8<\/strong>, implying annual growth of <strong>118.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>74.8<\/strong>, implying a prospective dividend yield of <strong>3.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>8.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>69.00<\/strong> cents and EPS of <strong>229.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.20%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>9.38<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>181.7<\/strong>, implying annual growth of <strong>-27.0%<\/strong>.<br \/>Current consensus DPS estimate is <strong>56.2<\/strong>, implying a prospective dividend yield of <strong>2.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>11.9<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SIG\">SIG<\/a>&nbsp;&nbsp;&nbsp; SIGMA HEALTHCARE LIMITED<\/h2>\n<p><strong>Health &amp; Nutrition &#8211; Overnight Price: $0.53 <\/strong><\/p>\n<p>Shaw and Partners rates ((SIG)) as Buy (1) &#8211;<\/p>\n<p>Sigma Healthcare has closed out its financial year with revenue of $3.45bn, up 1.3% on the previous comparable period, and gross profit of $112.5m, down -19.7% on the previous comparable period.&nbsp;Shaw and Partners notes revenue was stronger than expected.&nbsp;<\/p>\n<p>The company benefited from strong first half sales growth, but was challenged in the second half as the ERP implementation drove a loss of sales. Noting the delay in efficiencies gained from the ERP, the broker adjusts forecasts and increases&nbsp;FY25 earnings.&nbsp;<\/p>\n<p>The Buy rating and target price of $0.60 are retained.<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$0.60<\/strong> Current Price is <strong>$0.53 <\/strong> Difference: <strong>$0.07<\/strong><br \/>If <strong>SIG<\/strong> meets the Shaw and Partners target it will return approximately <strong> 13%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$0.51<\/strong>, suggesting downside of <strong>-4.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in January.<\/p>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>2.30<\/strong> cents and EPS of <strong>1.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.34%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>37.86<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>2.2<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>1.8<\/strong>, implying a prospective dividend yield of <strong>3.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>24.1<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY24:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY24<\/strong> dividend of <strong>2.50<\/strong> cents and EPS of <strong>2.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.72%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.28<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>N\/A<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>N\/A<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"STN\">STN<\/a>&nbsp;&nbsp;&nbsp; SATURN METALS LIMITED<\/h2>\n<p><strong>Gold &amp; Silver &#8211; Overnight Price: $0.38 <\/strong><\/p>\n<p>Shaw and Partners rates ((STN)) as Buy (1) &#8211;<\/p>\n<p>Results from bottle roll tests at&nbsp;Saturn Metals&#039; Apollo Hill ore project delivered an 81% recovery rate, offering potential for&nbsp;low cost processing.&nbsp;Shaw and Partners notes test results pave the way for a resource upgrade, as material considered waste could be leached.&nbsp;<\/p>\n<p>The broker expects&nbsp;Saturn Metals will release a substantial resource upgrade in coming weeks, following not only the test results but also twelve months of drilling. The company has identified mineralised prospects in a major geological corridor extending from Apollo Hill.<\/p>\n<p>The Buy rating and target price of $0.87 are retained.&nbsp;<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$0.87<\/strong> Current Price is <strong>$0.38 <\/strong> Difference: <strong>$0.49<\/strong><br \/>If <strong>STN<\/strong> meets the Shaw and Partners target it will return approximately <strong> 129%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 1.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 34.55<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 2.40<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 15.83<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TAH\">TAH<\/a>&nbsp;&nbsp;&nbsp; TABCORP HOLDINGS LIMITED<\/h2>\n<p><strong>Gaming &#8211; Overnight Price: $5.50 <\/strong><\/p>\n<p>Goldman Sachs rates ((TAH)) as Buy (1) &#8211;<\/p>\n<p>With The Lottery Corporation to commence trading as a separately listed entity on the ASX as of May 24, Tabcorp&nbsp;has provided detail on its forthcoming demerger booklet, with&nbsp;Goldman Sachs largely noting positives from company commentary.&nbsp;<\/p>\n<p>The company reiterated it considers the&nbsp;demerger the most certain path to maximising shareholder value, allowing each business to adopt a more focused profile, and&nbsp;Goldman Sachs is also of the view that the demerger is in the best interest of shareholders.&nbsp;<\/p>\n<p>At its current share price,&nbsp;Goldman Sachs feels investors are effectively paying for the lottery business and receiving the additional free benefit of the wagering and media business as a value add.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $6.20 from $6.00.&nbsp;<\/p>\n<p>This report was published on April 1, 2022.<\/p>\n<p>Target price is <strong>$6.20<\/strong> Current Price is <strong>$5.50 <\/strong> Difference: <strong>$0.7<\/strong><br \/>If <strong>TAH<\/strong> meets the Goldman Sachs target it will return approximately <strong> 13%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$5.79<\/strong>, suggesting upside of <strong>5.3%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>15.00<\/strong> cents and EPS of <strong>19.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.73%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>28.95<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>17.2<\/strong>, implying annual growth of <strong>39.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>13.6<\/strong>, implying a prospective dividend yield of <strong>2.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>32.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>18.70<\/strong> cents and EPS of <strong>23.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.40%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.91<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>21.2<\/strong>, implying annual growth of <strong>23.3%<\/strong>.<br \/>Current consensus DPS estimate is <strong>17.1<\/strong>, implying a prospective dividend yield of <strong>3.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>25.9<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TWE\">TWE<\/a>&nbsp;&nbsp;&nbsp; TREASURY WINE ESTATES LIMITED<\/h2>\n<p><strong>Food, Beverages &amp; Tobacco &#8211; Overnight Price: $11.57 <\/strong><\/p>\n<p>Jarden rates ((TWE)) as Buy (2) &#8211;<\/p>\n<p>Jarden&nbsp;reiterates its $13 target&nbsp;for&nbsp;Treasury Wine Estates and sees upside for&nbsp;the Treasury Premium Brands division. There&#039;s considered to be potential for expansion into China and scope for a Chinese Penfolds product (as per press speculation).<\/p>\n<p>The company remains a key Overweight rating for&nbsp;the broker due to low expectations. In addition, Treasury Wine Estates is seen as&nbsp;a reopening play, and a beneficiary of an improving global supply\/demand dynamic, as well as inflation.<\/p>\n<p>The&nbsp;medium-term operating backdrop for the company is the most favourable&nbsp;in recent years, according to the analyst.<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$13.00<\/strong> Current Price is <strong>$11.57 <\/strong> Difference: <strong>$1.43<\/strong><br \/>If <strong>TWE<\/strong> meets the Jarden target it will return approximately <strong> 12%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$13.34<\/strong>, suggesting upside of <strong>15.3%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>30.00<\/strong> cents and EPS of <strong>45.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.59%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>25.26<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>44.2<\/strong>, implying annual growth of <strong>27.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>26.9<\/strong>, implying a prospective dividend yield of <strong>2.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>26.2<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>34.00<\/strong> cents and EPS of <strong>56.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.94%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>20.41<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>54.8<\/strong>, implying annual growth of <strong>24.0%<\/strong>.<br \/>Current consensus DPS estimate is <strong>35.5<\/strong>, implying a prospective dividend yield of <strong>3.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>21.1<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"UWL\">UWL<\/a>&nbsp;&nbsp;&nbsp; UNITI GROUP LIMITED<\/h2>\n<p><strong>Telecommunication &#8211; Overnight Price: $4.75 <\/strong><\/p>\n<p>Bell Potter rates ((UWL)) as Downgrade to Hold from Buy (3) &#8211;<\/p>\n<p>Bell Potter considers it unlikely that&nbsp;Uniti Group will receive a better offer than the $5.00 per share bid&nbsp;from the Morrison-Brookfield consortium, and that the&nbsp;Uniti Group board is unlikely to recommend&nbsp;a better offer if&nbsp;it would incur payment of the $5m exclusivity fee.<\/p>\n<p>The broker expects a binding offer to be made in coming weeks, prior to the end of the exclusivity period.&nbsp;<\/p>\n<p>The rating is downgraded to Hold from Buy and the target price of $5.00 is retained.<\/p>\n<p>This report was published on April 1, 2022.<\/p>\n<p>Target price is <strong>$5.00<\/strong> Current Price is <strong>$4.75 <\/strong> Difference: <strong>$0.25<\/strong><br \/>If <strong>UWL<\/strong> meets the Bell Potter target it will return approximately <strong> 5%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>11.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>43.18<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>1.50<\/strong> cents and EPS of <strong>13.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.32%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>35.45<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Jarden rates ((UWL)) as Buy (1) &#8211;<\/p>\n<p>Jarden increases its target price to $5.00 from $4.39 for Uniti Group to align with the bid from&nbsp;HRL Morrison &amp; Co and Brookfield Infrastructure Group.<\/p>\n<p>Even though the Connect Consortium has a competing bid at the same price,&nbsp;Uniti Group finds certain terms and conditions too restrictive and chooses not to engage.<\/p>\n<p>Jarden maintains its Buy rating.<\/p>\n<p>This report was published on March 30, 2022.<\/p>\n<p>Target price is <strong>$5.00<\/strong> Current Price is <strong>$4.75 <\/strong> Difference: <strong>$0.25<\/strong><br \/>If <strong>UWL<\/strong> meets the Jarden target it will return approximately <strong> 5%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>11.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>43.18<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>13.10<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>36.26<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p><strong>Disclaimer:<\/strong><br \/>The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don&#039;t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.<\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are Breakaway Research, Edison Investment Research, Independent Investment Research, NDF Research, Pitt Street Research, and TMT Analytics.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Extra Edition of the Broker Call Report<\/p>\n","protected":false},"author":1,"featured_media":100686,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[84],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/100676"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=100676"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/100676\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media\/100686"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=100676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=100676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=100676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}